Medical Xpress October 10, 2024
Jacqueline Mitchell, Beth Israel Deaconess Medical Center

In a commentary published in The American Journal of Bioethics, Anthony P. Weiss, MD, MBA, MSc, Chief Medical Officer at Beth Israel Deaconess Medical Center (BIDMC), argues that the current approach to regulating artificial intelligence (AI) applications used in medicine is inadequate. Instead, Weiss proposes a model that mirrors the supervisory relationship between trainees and attending physicians.

Weiss focuses on the growing use of Medical Adaptive Machine Learning Systems (MAMLS), systems that continually learn and change, and the regulatory conundrum they present. Currently, MAMLS are thought of as something akin to , which must gain FDA approval before being used in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Technology
Google digs deeper into healthcare AI: 5 notes
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
How AI Has And Will Continue To Transform Healthcare
AI Translates Nature into New Medicines | StartUp Health Insights: Week of Nov 26, 2024
Building AI trust: The key role of explainability

Share This Article